STAT+: How one private biotech seized on JPM to emerge from stealth and tell its story
Out of stealth, Rezo Therapeutics seized on #JPM23 to tell its story.
News
STAT+: Pharmalittle: CRISPR-based drug shows promise in preliminary study; FDA user fee program prompts fresh worries over conflicts
Advocates for patients and doctors say the FDA “user fee” program has enabled the industry to weaken the approval process meant to ensure drugs are safe and effective […]
News
STAT+: Pharmalittle: FDA will review Biogen ALS drug despite inconclusive results; Shkreli launches drug-discovery software company
The FDA agreed to review a Biogen treatment for a rare, genetically defined form of ALS, even though a clinical trial failed to show a definitive benefit. […]
News
STAT+: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences
The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences. […]
